XERS

Xeris Biopharma Holdings, Inc. SEC filings

Every EDGAR filing for Xeris Biopharma Holdings, Inc. (XERS), newest first, with AI summaries and stories.

Ticker
XERS
CIK
1867096
Sector
Biotech and pharma
Latest filing
5d

Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9) · usually files the same day as earnings

Watch in the app Get the app

Get an email when Xeris Biopharma Holdings, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Insider activity

No open-market insider buys in the last 30 days.

Also: 4 open-market sales ($595K).

All XERS insider trades

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  2. ROUTINE4Xeris Biopharma Holdings, Inc.XERS

    3 insider filings

    Beth Hecht, insider filing for XERS

    Show all 3
    • 4Insider filing for XERS
    • 4Insider filing for XERS
    • 4Insider filing for XERS

    Beth Hecht

  7. ROUTINE4Xeris Biopharma Holdings, Inc.XERS

    3 insider filings

    Steven Pieper, insider filing for XERS

    Show all 3
    • 4Insider filing for XERS
    • 4Insider filing for XERS
    • 4Insider filing for XERS

    Steven Pieper, reporting

  8. ROUTINE4Xeris Biopharma Holdings, Inc.XERS

    2 insider filings

    John Patrick Shannon Jr, insider filing for XERS

    Show all 2
    • 4Insider filing for XERS
    • 4Insider filing for XERS

    John Patrick Shannon Jr, reporting

  13. ROUTINE4Xeris Biopharma Holdings, Inc.XERS

    2 insider filings

    Kevin McCulloch, insider filing for XERS

    Show all 2
    • 4Insider filing for XERS
    • 4Insider filing for XERS

    Kevin McCulloch, reporting

  19. ROUTINE4Xeris Biopharma Holdings, Inc.XERS

    2 insider filings

    Nerissa Kreher, insider filing for XERS

    Show all 2
    • 4Insider filing for XERS
    • 3New insider at XERS

    Nerissa Kreher, reporting

  20. ROUTINE4Xeris Biopharma Holdings, Inc.XERS

    2 insider filings

    Kevin McCulloch, insider filing for XERS

    Show all 2
    • 4Insider filing for XERS
    • 4Insider filing for XERS

    Kevin McCulloch, reporting

  21. ROUTINE144Xeris Biopharma Holdings, Inc.XERS

    2 Form 144 notices

    Beth Hecht, planned sale of XERS shares

    Show all 2
    • 144Planned insider sale of XERS shares
    • 144Planned insider sale of XERS shares

    Beth Hecht, reporting

  24. ROUTINE4Xeris Biopharma Holdings, Inc.XERS

    6 insider filings

    Garheng Kong, insider filing for XERS

    Show all 6
    • 4Insider filing for XERS
    • 4Insider filing for XERS
    • 4Insider filing for XERS
    • 4Insider filing for XERS
    • 4Insider filing for XERS
    • 4Insider filing for XERS

    Garheng Kong, reporting

  26. ROUTINE144Xeris Biopharma Holdings, Inc.XERS

    3 Form 144 notices

    Dawn Halkuff, planned sale of XERS shares

    Show all 3
    • 144Planned insider sale of XERS shares
    • 144Planned insider sale of XERS shares
    • 144Planned insider sale of XERS shares

    Dawn Halkuff, reporting

Older filings on EDGAR